136 related articles for article (PubMed ID: 9671955)
1. Clinical application of K-ras oncogene mutations in pancreatic carcinoma: detection of micrometastases.
Nomoto S; Nakao A; Ando N; Takeda S; Kasai Y; Inoue S; Kaneko T; Takagi H
Semin Surg Oncol; 1998; 15(1):40-6. PubMed ID: 9671955
[TBL] [Abstract][Full Text] [Related]
2. Detection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma.
Ando N; Nakao A; Nomoto S; Takeda S; Kaneko T; Kurokawa T; Nonami T; Takagi H
Pancreas; 1997 Nov; 15(4):374-8. PubMed ID: 9361091
[TBL] [Abstract][Full Text] [Related]
3. Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis.
Inoue S; Nakao A; Kasai Y; Harada A; Nonami T; Takagi H
Jpn J Cancer Res; 1995 Jul; 86(7):626-30. PubMed ID: 7559078
[TBL] [Abstract][Full Text] [Related]
4. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
Banerjee SK; Makdisi WF; Weston AP; Campbell DR
Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
[TBL] [Abstract][Full Text] [Related]
5. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.
Niedergethmann M; Rexin M; Hildenbrand R; Knob S; Sturm JW; Richter A; Post S
Am J Surg Pathol; 2002 Dec; 26(12):1578-87. PubMed ID: 12459624
[TBL] [Abstract][Full Text] [Related]
7. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry and molecular detection of nodal micrometastases in pancreatic cancer.
Brown HM; Ahrendt SA; Komorowski RA; Doffek KM; Wilson SD; Demeure MJ
J Surg Res; 2001 Feb; 95(2):141-6. PubMed ID: 11162037
[TBL] [Abstract][Full Text] [Related]
9. Detection of multiple hepatic micrometastases in pancreatic adenocarcinoma with a solitary liver metastasis by direct sequencing of the K-ras gene: a case report.
Suwa H; Hosotani R; Okino T; Monden K; Arii S; Inoue K; Kogire M; Ohshio G; Fukumoto M; Imamura M
Surgery; 1999 Jan; 125(1):113-6. PubMed ID: 9889807
[No Abstract] [Full Text] [Related]
10. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay.
Demeure MJ; Doffek KM; Komorowski RA; Wilson SD
Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933
[TBL] [Abstract][Full Text] [Related]
11. [Detection of point mutations on the Ki-ras gene using the PCR technique].
Janda J; Krechler T; Dufek V; Klener P
Cesk Patol; 1998 Jan; 34(1):33-7. PubMed ID: 9560882
[TBL] [Abstract][Full Text] [Related]
12. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
[TBL] [Abstract][Full Text] [Related]
13. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
14. Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears.
Apple SK; Hecht JR; Novak JM; Nieberg RK; Rosenthal DL; Grody WW
Am J Clin Pathol; 1996 Mar; 105(3):321-6. PubMed ID: 8602613
[TBL] [Abstract][Full Text] [Related]
15. C-Ki-ras mutations in peripheral blood of pancreatic cancer patients: a marker for early tumor metastasis.
Mohiuddin M; Ahmed MM; Venkatasubbarao K
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):161-6. PubMed ID: 12118546
[TBL] [Abstract][Full Text] [Related]
16. Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients.
Hruban RH; Sturm PD; Slebos RJ; Wilentz RE; Musler AR; Yeo CJ; Sohn TA; van Velthuysen ML; Offerhaus GJ
Am J Pathol; 1997 Oct; 151(4):943-9. PubMed ID: 9327727
[TBL] [Abstract][Full Text] [Related]
17. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
[TBL] [Abstract][Full Text] [Related]
18. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
19. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice.
Furuya N; Kawa S; Akamatsu T; Furihata K
Gastroenterology; 1997 Aug; 113(2):593-8. PubMed ID: 9247481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]